Clinical Trial Update: A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of DSP-7888 Dosing Emulsion in combination with immune checkpoint inhibitors in adults with advanced solid tumors was terminated; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Peritoneal Cancer
• Platinum-resistant Ovarian Cancer
• Renal Cell Carcinoma
• Serous Epithelial Ovarian Cancer
• Urothelial Carcinoma

Drugs mentioned

• DSP-7888 Dosing Emulsion

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Renal Cell Carcinoma (RCC), Urothelial Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-04-18